8-K current report · filed Aug 3, 2026

Sabra Health Care REIT, Inc. (SBRA) 8-K Current Report: August 3, 2026

Item 2.02Item 7.01Item EX-99.12Item EX-99.22Item EX-99.32Item EX-99.42Item EX-99.1SBRA overview

Short answer

Sabra Health Care REIT, Inc. (SBRA) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.12 (Exhibit EX-99.12), Item EX-99.22 (Exhibit EX-99.22), Item EX-99.32 (Exhibit EX-99.32), Item EX-99.42 (Exhibit EX-99.42), Item EX-99.1 (Item EX-99.1). Sabra reported second-quarter 2026 results for the three months ended June 30, 2026.

Sabra Health Care REIT, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Sabra reported second-quarter 2026 results for the three months ended June 30, 2026
  • Press release furnished as Exhibit 99.1, with non-GAAP reconciliations in Exhibit 99.3
  • Investors should review the exhibits for operating performance and non-GAAP metrics valuing REIT earnings

Item 7.01 · Regulation FD Disclosure

  • Supplemental information package furnished as Exhibit 99.2 and available on Sabra’s investor website
  • Exhibit 99.4 presentation materials intended for investor presentations
  • Materials under Items 2.02 and 7.01 excluded from Exchange Act Section 18 filing liability
  • Exhibits 99.1–99.4 not incorporated into other filings unless expressly referenced

Item EX-99.1 · Item EX-99.1

  • Q2 normalized FFO $0.38 and normalized AFFO $0.40 per share, supporting the $0.30 quarterly dividend
  • GAAP net loss $(0.10) per share, driven by a $102.4M provision for loan losses and other reserves
  • $274.1M invested during Q2 at an 8.1% initial cash yield, with $223.0M of additional acquisitions completed after quarter-end
  • Same-property managed senior housing cash NOI increased 13.7% year over year, signaling strong operating momentum
  • Liquidity approximately $1.3B and net debt to adjusted EBITDA 4.61x, preserving capacity for further acquisitions

Item EX-99.12 · Exhibit EX-99.12

  • Q2 normalized FFO $0.38 and normalized AFFO $0.40 per share, supporting the $0.30 quarterly dividend
  • GAAP net loss $(0.10) per share, driven by a $102.4 million provision for loan losses and other reserves
  • $274.1 million invested during Q2 at an 8.1% initial cash yield, with $599.0 million closed year to date
  • Additional $223.0 million acquisition of seven managed senior housing properties after quarter end, targeting unlevered IRRs in the teens
  • Net Debt to Adjusted EBITDA 4.61x, supported by approximately $1.3 billion liquidity but with meaningful forward-equity dilution exposure

Item EX-99.22 · Exhibit EX-99.22

  • Q2 2026 revenue $235.9M, up from $189.2M, driven by managed senior housing expansion
  • Net loss $25.2M, reflecting $102.4M provision for loan losses and other reserves
  • Normalized FFO $0.38 per share, exceeding $0.30 quarterly dividend and supporting payout coverage
  • Managed portfolio occupancy 85.4%, with same-store occupancy 88.2% and cash NOI margin 34.1%
  • Debt $2.65B, leverage 4.61x net debt to adjusted EBITDA, with $317.5M revolver outstanding maturing in 2027

Item EX-99.32 · Exhibit EX-99.32

  • 2026 normalized FFO guidance $1.53-$1.55 per share, normalized AFFO $1.59-$1.61
  • Guidance assumes low-single-digit triple-net Cash NOI growth and low-to-mid-teens same-store managed-housing Cash NOI growth
  • Q2 normalized FFO $0.38 per share, up from $0.37, despite GAAP net loss of $25.2 million
  • $102.4 million Q2 provision for loan losses materially depressed GAAP results and FFO, but was excluded from normalized metrics
  • Net debt $2.41 billion, leverage 4.61x annualized adjusted EBITDA, highlighting meaningful balance-sheet exposure

Item EX-99.42 · Exhibit EX-99.42

  • 2026 guidance reiterated: normalized FFO $1.53-$1.55 and normalized AFFO $1.59-$1.61 per diluted share
  • Guidance midpoint implies approximately 7% normalized FFO and 8% normalized AFFO year-over-year growth
  • Year-to-date investments reached $599 million at an estimated 7.5% initial cash yield, supporting external growth
  • Awarded investment pipeline totals $100 million at an estimated 7.7% initial cash yield
  • Avamere re-tenanting covers 26 properties and $53 million annualized cash rent, with completion expected in the second half of 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Sabra Health Care REIT, Inc. 8-K filings

Get the next SBRA 8-K as it lands

Follow SBRA for push alerts, or ask the research agent what this filing means.